201 related articles for article (PubMed ID: 17490765)
1. Sildenafil improves the alveolar-capillary function in heart failure patients.
Bussotti M; Montorsi P; Amato M; Magini A; Baldassarre D; Tantardini F; Veglia F; Agostoni P
Int J Cardiol; 2008 May; 126(1):68-72. PubMed ID: 17490765
[TBL] [Abstract][Full Text] [Related]
2. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil improves exercise capacity and quality of life in patients with systolic heart failure and secondary pulmonary hypertension.
Lewis GD; Shah R; Shahzad K; Camuso JM; Pappagianopoulos PP; Hung J; Tawakol A; Gerszten RE; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Oct; 116(14):1555-62. PubMed ID: 17785618
[TBL] [Abstract][Full Text] [Related]
4. Spironolactone improves lung diffusion in chronic heart failure.
Agostoni P; Magini A; Andreini D; Contini M; Apostolo A; Bussotti M; Cattadori G; Palermo P
Eur Heart J; 2005 Jan; 26(2):159-64. PubMed ID: 15618072
[TBL] [Abstract][Full Text] [Related]
5. Exercise-induced pulmonary edema in heart failure.
Agostoni P; Cattadori G; Bianchi M; Wasserman K
Circulation; 2003 Nov; 108(21):2666-71. PubMed ID: 14581402
[TBL] [Abstract][Full Text] [Related]
6. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure.
Lewis GD; Lachmann J; Camuso J; Lepore JJ; Shin J; Martinovic ME; Systrom DM; Bloch KD; Semigran MJ
Circulation; 2007 Jan; 115(1):59-66. PubMed ID: 17179022
[TBL] [Abstract][Full Text] [Related]
7. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibition restores the diffusing capacity for carbon monoxide in patients with chronic heart failure by improving the molecular diffusion across the alveolar capillary membrane.
Guazzi M; Agostoni P
Clin Sci (Lond); 1999 Jan; 96(1):17-22. PubMed ID: 9857102
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide and exercise performance in heart failure.
Agostoni P; Bussotti M
Arch Physiol Biochem; 2003 Oct; 111(4):293-6. PubMed ID: 15764057
[TBL] [Abstract][Full Text] [Related]
10. Gas diffusion and alveolar-capillary unit in chronic heart failure.
Agostoni P; Bussotti M; Cattadori G; Margutti E; Contini M; Muratori M; Marenzi G; Fiorentini C
Eur Heart J; 2006 Nov; 27(21):2538-43. PubMed ID: 17028107
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 5 inhibition with sildenafil reverses exercise oscillatory breathing in chronic heart failure: a long-term cardiopulmonary exercise testing placebo-controlled study.
Guazzi M; Vicenzi M; Arena R
Eur J Heart Fail; 2012 Jan; 14(1):82-90. PubMed ID: 22067410
[TBL] [Abstract][Full Text] [Related]
12. Alveolar--capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure.
Guazzi M; Pontone G; Brambilla R; Agostoni P; Rèina G
Eur Heart J; 2002 Mar; 23(6):467-76. PubMed ID: 11863349
[TBL] [Abstract][Full Text] [Related]
13. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
14. [Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise].
Chi L; Liu Y; Piao Z
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):344-7. PubMed ID: 11326890
[TBL] [Abstract][Full Text] [Related]
15. Reduced rate of alveolar-capillary recruitment and fall of pulmonary diffusing capacity during exercise in patients with heart failure.
Olson LJ; Snyder EM; Beck KC; Johnson BD
J Card Fail; 2006 May; 12(4):299-306. PubMed ID: 16679264
[TBL] [Abstract][Full Text] [Related]
16. Influences of sildenafil on lung function and hemodynamics in patients with chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Guazzi MD
Clin Pharmacol Ther; 2004 Oct; 76(4):371-8. PubMed ID: 15470337
[TBL] [Abstract][Full Text] [Related]
17. Endothelium-mediated modulation of ergoreflex and improvement in exercise ventilation by acute sildenafil in heart failure patients.
Guazzi M; Casali M; Berti F; Rossoni G; Colonna VD; Guazzi MD
Clin Pharmacol Ther; 2008 Feb; 83(2):336-41. PubMed ID: 17653139
[TBL] [Abstract][Full Text] [Related]
18. Long-term use of sildenafil in the therapeutic management of heart failure.
Guazzi M; Samaja M; Arena R; Vicenzi M; Guazzi MD
J Am Coll Cardiol; 2007 Nov; 50(22):2136-44. PubMed ID: 18036451
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibition facilitates alveolar-capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction.
Guazzi M; Melzi G; Marenzi GC; Agostoni P
Clin Pharmacol Ther; 1999 Mar; 65(3):319-27. PubMed ID: 10096264
[TBL] [Abstract][Full Text] [Related]
20. Influence of sildenafil on lung diffusion during exposure to acute hypoxia at rest and during exercise in healthy humans.
Snyder EM; Olson TP; Johnson BD; Frantz RP
Eur J Appl Physiol; 2008 Jul; 103(4):421-30. PubMed ID: 18369657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
